{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:36:35Z","timestamp":1771576595633,"version":"3.50.1"},"reference-count":43,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>With the introduction of genomic technologies, more hereditary cancer syndromes with hematologic malignancies are being described. Up to 10% of hematologic malignancies in children and adults may be the result of an underlying inherited genetic risk. Managing these patients with hereditary hematologic malignancies, including familial leukemia, remains a clinical challenge because there is little information about these relatively rare disorders. This article covers some of the issues related to the diagnosis and interpretation of variants associated with hereditary hematologic malignancies, including the importance of an accurate family history in interpreting genetic variants associated with disease. The challenges of screening other family members and offering the most appropriate early malignancy detection is also discussed. We now have a good opportunity to better define hereditary cancer syndromes with associated hematologic malignancies and contribute to clinically effective guidelines.<\/jats:p>","DOI":"10.1182\/asheducation-2016.1.309","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T16:05:27Z","timestamp":1480694727000},"page":"309-315","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Discussing and managing hematologic germ line variants"],"prefix":"10.1182","volume":"2016","author":[{"given":"Wendy","family":"Kohlmann","sequence":"first","affiliation":[{"name":"Family Cancer Assessment Clinic, Huntsman Cancer Institute, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Schiffman","sequence":"additional","affiliation":[{"name":"Family Cancer Assessment Clinic, Huntsman Cancer Institute, and"},{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, University of Utah, Salt Lake City, UT"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"1","key":"2019111703280890600_B1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.beha.2014.11.004","article-title":"Genetic predisposition syndromes: when should they be considered in the work-up of MDS?","volume":"28","author":"Babushok","year":"2015","journal-title":"Best Pract Res Clin Haematol"},{"issue":"9","key":"2019111703280890600_B2","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/bmt.2015.117","article-title":"Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes","volume":"50","author":"Peffault de Latour","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111703280890600_B3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejmg.2016.01.003","article-title":"Acute lymphoblastic leukemia in the context of RASopathies","volume":"59","author":"Cav\u00e9","year":"2016","journal-title":"Eur J Med Genet"},{"issue":"5","key":"2019111703280890600_B4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s10897-014-9807-3","article-title":"Genetic Information-Seeking Behaviors and Knowledge Among Family Members and Patients With Inherited Bone Marrow Failure Syndromes","volume":"24","author":"Hamilton","year":"2015","journal-title":"J Genet Couns"},{"issue":"4","key":"2019111703280890600_B5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11899-016-0328-z","article-title":"Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant","volume":"11","author":"Barata","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"issue":"8","key":"2019111703280890600_B6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1200\/JCO.2013.50.9257","article-title":"American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers","volume":"32","author":"Lu","year":"2014","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111703280890600_B7","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2015-10-676098","article-title":"Novel germ line DDX41 mutations define families with a lower age of MDS\/AML onset and lymphoid malignancies","volume":"127","author":"Lewinsohn","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2019111703280890600_B8","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.3324\/haematol.2015.139790","article-title":"Two novel germline DDX41 mutations in a family with inherited myelodysplasia\/acute myeloid leukemia","volume":"101","author":"Li","year":"2016","journal-title":"Haematologica"},{"issue":"8","key":"2019111703280890600_B9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1182\/blood-2016-01-690909","article-title":"Inherited DDX41 mutations: 11 genes and counting","volume":"127","author":"Tawana","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2019111703280890600_B10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jnci\/djj005","article-title":"Reliability of self-reported family history of cancer in a large case-control study of lymphoma","volume":"98","author":"Chang","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2019111703280890600_B11","first-page":"279","article-title":"Collection of family health history for assessment of chronic disease risk in primary care","volume":"74","author":"Powell","year":"2013","journal-title":"N C Med J"},{"key":"2019111703280890600_B12","article-title":"Fanconi anemia","author":"Alter"},{"key":"2019111703280890600_B13","doi-asserted-by":"crossref","article-title":"Dyskeratosis Congenita","author":"Savage","DOI":"10.1016\/j.hoc.2009.01.003"},{"issue":"9","key":"2019111703280890600_B14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103270","article-title":"Improving diagnostic precision, care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes","volume":"52","author":"Ghemlas","year":"2015","journal-title":"J Med Genet"},{"key":"2019111703280890600_B15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/nyas.12346","article-title":"Familial myelodysplastic syndrome\/acute leukemia syndromes: a review and utility for translational investigations","volume":"1310","author":"West","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"2019111703280890600_B16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/j.seminhematol.2014.08.001","article-title":"Inherited predisposition to acute myeloid leukemia","volume":"51","author":"Godley","year":"2014","journal-title":"Semin Hematol"},{"key":"2019111703280890600_B17","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.14694\/EdBook_AM.2014.34.e44","article-title":"Predisposition to pediatric and hematologic cancers: a moving target","author":"Malkin","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"31","key":"2019111703280890600_B18","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","article-title":"American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility","volume":"33","author":"Robson","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111703280890600_B19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10897-011-9462-x","article-title":"Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors","volume":"21","author":"Riley","year":"2012","journal-title":"J Genet Couns"},{"issue":"6","key":"2019111703280890600_B20","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s10897-014-9754-z","article-title":"Genetic counseling for Fanconi anemia: crosslinking disciplines","volume":"23","author":"Zierhut","year":"2014","journal-title":"J Genet Couns"},{"issue":"5","key":"2019111703280890600_B21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bmt.1702170","article-title":"Buccal swabs but not mouthwash samples can be used to obtain pretransplant DNA fingerprints from recipients of allogeneic bone marrow transplants","volume":"25","author":"Thiede","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111703280890600_B22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/jpepsy\/24.2.131","article-title":"Empirically supported treatments in pediatric psychology: procedure-related pain","volume":"24","author":"Powers","year":"1999","journal-title":"J Pediatr Psychol"},{"issue":"7","key":"2019111703280890600_B23","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/cncr.29172","article-title":"Perinatal and familial risk factors for acute lymphoblastic leukemia in a Swedish national cohort","volume":"121","author":"Crump","year":"2015","journal-title":"Cancer"},{"key":"2019111703280890600_B24","first-page":"125","article-title":"Medical history, lifestyle, family history and occupational risk factors for adult acute lymphocytic leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"48","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"10","key":"2019111703280890600_B25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1023\/A:1013758114381","article-title":"Family cancer history and risk of childhood acute leukemia (France)","volume":"12","author":"Perrillat","year":"2001","journal-title":"Cancer Causes Control"},{"issue":"5","key":"2019111703280890600_B26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.cej.0000243849.82232.cb","article-title":"Familial history of cancer and childhood acute leukemia: a French population-based case-control study","volume":"16","author":"Ripert","year":"2007","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"2019111703280890600_B27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canep.2011.06.004","article-title":"Family history of cancer and non-malignant diseases and risk of childhood acute lymphoblastic leukemia: a Children\u2019s Oncology Group Study","volume":"36","author":"Zierhut","year":"2012","journal-title":"Cancer Epidemiol"},{"issue":"10","key":"2019111703280890600_B28","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/ijc.28266","article-title":"Familial risk of childhood cancer and tumors in the Li-Fraumeni spectrum in the Utah Population Database: implications for genetic evaluation in pediatric practice","volume":"133","author":"Curtin","year":"2013","journal-title":"Int J Cancer"},{"issue":"11","key":"2019111703280890600_B29","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"29","author":"Plon","year":"2008","journal-title":"Hum Mutat"},{"issue":"6","key":"2019111703280890600_B30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ajhg.2016.03.024","article-title":"Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium","volume":"98","author":"Amendola","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"5","key":"2019111703280890600_B31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1634\/theoncologist.2012-0452","article-title":"BRCA1\/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management","volume":"18","author":"Lindor","year":"2013","journal-title":"Oncologist"},{"issue":"10","key":"2019111703280890600_B32","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/pon.1467","article-title":"Distress among women receiving uninformative BRCA1\/2 results: 12-month outcomes","volume":"18","author":"O\u2019Neill","year":"2009","journal-title":"Psychooncology"},{"issue":"2","key":"2019111703280890600_B33","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/cncr.26294","article-title":"Long-term outcomes of BRCA1\/BRCA2 testing: risk reduction and surveillance","volume":"118","author":"Schwartz","year":"2012","journal-title":"Cancer"},{"key":"2019111703280890600_B34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/bmt.2015.15","article-title":"Related hematopoietic cell donor care: is there are role for unrelated donor registries?","volume":"50","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111703280890600_B35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1158\/1055-9965.EPI-11-0991","article-title":"Long-term psychosocial outcomes of BRCA1\/BRCA2 testing: differences across affected status and risk-reducing surgery choice","volume":"21","author":"Graves","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"2019111703280890600_B36","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1007\/s10620-015-3626-8","article-title":"Psychosocial Impact of Lynch Syndrome and Affected Individuals and Families","volume":"60","author":"Galiatsatos","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"2","key":"2019111703280890600_B37","first-page":"296","article-title":"Recommendations for managing the donation of haematopoietic stem cells from related and unrelated donors for allogeneic transplantation","volume":"11","author":"Aprili","year":"2013","journal-title":"Blood Transfus"},{"issue":"10","key":"2019111703280890600_B38","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/bmt.2015.152","article-title":"Hematopoietic stem cell donation: psychological perspectives of pediatric sibling donors and their parents","volume":"50","author":"Hutt","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2019111703280890600_B39","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/bmt.2014.67","article-title":"Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee","volume":"49","author":"Lown","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111703280890600_B40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study","volume":"12","author":"Villani","year":"2011","journal-title":"Lancet Oncol"},{"issue":"5","key":"2019111703280890600_B41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/jmedgenet-2013-102238","article-title":"Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium \u201cCare for CMMR-D\u201d (C4CMMR-D)","volume":"51","author":"Vasen","year":"2014","journal-title":"J Med Genet"},{"issue":"9","key":"2019111703280890600_B42","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol"},{"issue":"6","key":"2019111703280890600_B43","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/pbc.24417","article-title":"Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing","volume":"60","author":"Powell","year":"2013","journal-title":"Pediatr Blood Cancer"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2016\/1\/309\/1249990\/hem088424.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2016\/1\/309\/1249990\/hem088424.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T08:28:38Z","timestamp":1573979318000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2016\/1\/309\/21012\/Discussing-and-managing-hematologic-germ-line"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12,2]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2016.1.309","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]}}}